Given the roles of S2R in regulating autophagy, as demonstrated in other models, targeting S2R to reverse amyloid-β toxicity may be beneficial in the context of autophagic dysfunction in Alzheimer’s disease. Here, TMEM97 is linked to early-onset autosomal dominant Alzheimer disease.